Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 51

    1.

    Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function.

    Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS; the Type 1 Diabetes TrialNet Anti-CD20 Study Group.

    N Engl J Med. 2009 Nov 26;361(22):2143-2152.PMID: 19940299 [PubMed - as supplied by publisher]

    2.

    Preservation of beta-cell function in autoantibody-positive youth with diabetes.

    Greenbaum CJ, Anderson AM, Dolan LM, Mayer-Davis EJ, Dabelea D, Imperatore G, Marcovina S, Pihoker C; SEARCH Study Group.

    Diabetes Care. 2009 Oct;32(10):1839-44. Epub 2009 Jul 8.PMID: 19587365 [PubMed - in process]Related articles

    3.

    Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articles

    4.

    Changes in autoreactive T cell avidity during type 1 diabetes development.

    Standifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT.

    Clin Immunol. 2009 Sep;132(3):312-20. Epub 2009 May 23.PMID: 19482555 [PubMed - indexed for MEDLINE]Related articles

    5.

    Omental Roll-Up: A Technique for Islet Engraftment in a Large Animal Model.

    Hefty TR, Kuhr CS, Chong KT, Guinee DG, Wang W, Reems JA, Greenbaum CJ.

    J Surg Res. 2008 Dec 13. [Epub ahead of print]PMID: 19394649 [PubMed - as supplied by publisher]Related articles

    6.

    Type 1 Diabetes TrialNet--an international collaborative clinical trials network.

    Skyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L; Type 1 Diabetes TrialNet Study Group.

    Ann N Y Acad Sci. 2008 Dec;1150:14-24.PMID: 19120262 [PubMed - indexed for MEDLINE]Related articles

    7.

    Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.

    Bollyky J, Sanda S, Greenbaum CJ.

    Mt Sinai J Med. 2008 Aug;75(4):385-97. Review.PMID: 18729155 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

    Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group.

    Diabetes Care. 2008 Oct;31(10):1966-71. Epub 2008 Jul 15.PMID: 18628574 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Standardization of C-peptide measurements.

    Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT.

    Clin Chem. 2008 Jun;54(6):1023-6. Epub 2008 Apr 17.PMID: 18420730 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus.

    Krudys KM, Greenbaum CJ, Pihoker C, Vicini P.

    Metabolism. 2008 Apr;57(4):445-7.PMID: 18328342 [PubMed - indexed for MEDLINE]Related articles

    11.

    A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

    Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.

    Bollyky J, Greenbaum CJ.

    J Clin Endocrinol Metab. 2007 Aug;92(8):2879-81. No abstract available. PMID: 17682088 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    International comparison of C-peptide measurements.

    Wiedmeyer HM, Polonsky KS, Myers GL, Little RR, Greenbaum CJ, Goldstein DE, Palmer JP.

    Clin Chem. 2007 Apr;53(4):784-7. Epub 2007 Mar 1.PMID: 17332147 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives.

    Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Greenbaum CJ, Pihoker C, Nepom GT.

    Diabetes. 2006 Nov;55(11):3061-7.PMID: 17065343 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.

    Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC.

    Diabetes. 2006 Sep;55(9):2588-94.PMID: 16936208 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

    Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.

    Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA.

    Scand J Immunol. 2006 Jan;63(1):59-69.PMID: 16398702 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluation of leptin levels in subjects at risk for type 1 diabetes.

    Gilliam LK, Jensen RA, Yang P, Weigle DS, Greenbaum CJ, Pihoker C.

    J Autoimmun. 2006 Mar;26(2):133-7. Epub 2005 Dec 27.PMID: 16380228 [PubMed - indexed for MEDLINE]Related articles

    21.

    Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.

    Gilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C.

    J Autoimmun. 2005 Nov;25(3):244-50. Epub 2005 Oct 21.PMID: 16243484 [PubMed - indexed for MEDLINE]Related articles

    22.

    Latent autoimmune diabetes in adults (LADA) should be less latent.

    Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC.

    Diabetologia. 2005 Nov;48(11):2206-12. Epub 2005 Sep 29. Review.PMID: 16193284 [PubMed - indexed for MEDLINE]Related articles

    23.

    Non-invasive imaging of beta cell mass: a quantitative analysis.

    Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Krohn KA.

    Diabetes Technol Ther. 2004 Oct;6(5):652-9.PMID: 15628819 [PubMed - indexed for MEDLINE]Related articles

    24.

    High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes.

    Greenbaum CJ, Eisenbarth G, Atkinson M, Yu L, Babu S, Schatz D, Zeidler A, Orban T, Wasserfall C, Cuthbertson D, Krischer J; DPT-1 study group.

    Diabetologia. 2005 Jan;48(1):68-74. Epub 2004 Dec 16.PMID: 15602651 [PubMed - indexed for MEDLINE]Related articles

    25.

    Autoimmunity to islet proteins in children diagnosed with new-onset diabetes.

    Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C.

    J Clin Endocrinol Metab. 2004 May;89(5):2222-7.PMID: 15126545 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Systematic screening of potential beta-cell imaging agents.

    Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Wallen AR, Marcum ES, Stekhova SA, Krohn KA.

    Biochem Biophys Res Commun. 2004 Feb 20;314(4):976-83.PMID: 14751228 [PubMed - indexed for MEDLINE]Related articles

    27.

    C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

    Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

    Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934. PMID: 14693724 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.

    Greenbaum CJ, Harrison LC; Immunology of Diabetes Society.

    Diabetes. 2003 May;52(5):1059-65. No abstract available. Erratum in: Diabetes. 2003 Oct;52(10):2643. PMID: 12716733 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation.

    Plesner A, Greenbaum CJ, Gaur LK, Ernst RK, Lernmark A.

    Scand J Immunol. 2002 Nov;56(5):522-9.PMID: 12410803 [PubMed - indexed for MEDLINE]Related articles

    30.

    Type 1 diabetes intervention trials: what have we learned? A critical review of selected intervention trials.

    Greenbaum CJ.

    Clin Immunol. 2002 Aug;104(2):97-104. Review.PMID: 12165270 [PubMed - indexed for MEDLINE]Related articles

    31.

    Insulin resistance in type 1 diabetes.

    Greenbaum CJ.

    Diabetes Metab Res Rev. 2002 May-Jun;18(3):192-200. Review.PMID: 12112937 [PubMed - indexed for MEDLINE]Related articles

    32.

    Dynamic perifusion to maintain and assess isolated pancreatic islets.

    Sweet IR, Cook DL, Wiseman RW, Greenbaum CJ, Lernmark A, Matsumoto S, Teague JC, Krohn KA.

    Diabetes Technol Ther. 2002;4(1):67-76.PMID: 12017423 [PubMed - indexed for MEDLINE]Related articles

    33.

    Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

    Greenbaum CJ, Prigeon RL, D'Alessio DA.

    Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types.

    Greenbaum CJ, Gaur LK, Noble JA.

    J Autoimmun. 2002 Feb;18(1):67-70.PMID: 11869048 [PubMed - indexed for MEDLINE]Related articles

    35.

    Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.

    Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP.

    Metabolism. 2001 Sep;50(9):1008-13.PMID: 11555830 [PubMed - indexed for MEDLINE]Related articles

    36.

    Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

    Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

    Diabetes. 2001 Feb;50(2):470-6.PMID: 11272162 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Low serum conditions for in vitro generation of human macrophages with macrophage colony stimulating factor.

    Plesner A, Greenbaum CJ, Lernmark A.

    J Immunol Methods. 2001 Mar 1;249(1-2):53-61.PMID: 11226463 [PubMed - indexed for MEDLINE]Related articles

    38.

    Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1.

    Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1255-60.PMID: 10720072 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.

    Brooks-Worrell BM, Juneja R, Minokadeh A, Greenbaum CJ, Palmer JP.

    Diabetes. 1999 May;48(5):983-8.PMID: 10331401 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.

    Greenbaum CJ, Kahn SE, Palmer JP.

    Diabetes. 1996 Nov;45(11):1631-4.PMID: 8866571 [PubMed - indexed for MEDLINE]Related articles

    42.

    Short-term responses to periodontal therapy in insulin-dependent diabetic patients.

    Smith GT, Greenbaum CJ, Johnson BD, Persson GR.

    J Periodontol. 1996 Aug;67(8):794-802. Erratum in: J Periodontol 1996 Dec;67(12):1368. PMID: 8866319 [PubMed - indexed for MEDLINE]Related articles

    43.

    Prospective evaluation of beta-cell function in insulin autoantibody-positive relatives of insulin-dependent diabetic patients.

    Neifing JL, Greenbaum CJ, Kahn SE, McCulloch DK, Barmeier H, Lernmark A, Palmer JP.

    Metabolism. 1993 Apr;42(4):482-6.PMID: 8487672 [PubMed - indexed for MEDLINE]Related articles

    44.

    Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop.

    Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WA, MacLaren NK, Lernmark A.

    Diabetes. 1992 Dec;41(12):1570-4.PMID: 1446798 [PubMed - indexed for MEDLINE]Related articles

    45.

    Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes.

    Hegewald MJ, Schoenfeld SL, McCulloch DK, Greenbaum CJ, Klaff LJ, Palmer JP.

    J Immunol Methods. 1992 Sep 18;154(1):61-8.PMID: 1401944 [PubMed - indexed for MEDLINE]Related articles

    46.

    Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories.

    Greenbaum CJ, Wilkin TJ, Palmer JP.

    Diabetologia. 1992 Aug;35(8):798-800. No abstract available. PMID: 1511809 [PubMed - indexed for MEDLINE]Related articles

    48.

    Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.

    Greenbaum CJ, Havel PJ, Taborsky GJ Jr, Klaff LJ.

    J Clin Invest. 1991 Sep;88(3):767-73.PMID: 1679440 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Insulin antibodies and insulin autoantibodies.

    Greenbaum CJ, Palmer JP.

    Diabet Med. 1991 Feb-Mar;8(2):97-105. Review. No abstract available. PMID: 1827408 [PubMed - indexed for MEDLINE]Related articles

    50.

    Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.

    McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Mauseth RS, Benson EA, Nepom GT, Shewey L, Palmer JP.

    Diabetes. 1990 May;39(5):549-56.PMID: 2185106 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...